|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4900 CAD | -2.00% |
|
-5.77% | +7.69% |
| 07-14 | PharmaCorp to Seek Acquisition Opportunities | CI |
| 07-14 | PharmaCorp Rx Closes C$11.5 Million Bought-Deal Offering of Share Units | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 49x | - | -0.25x | 1.81x | 18.37x | 40.72x | - | 60.57M | ||
| 17.39x | 1.53x | 2.16x | 0.72x | 11.3x | 12.13x | -.--% | 15.05B | ||
| 22.77x | 2.52x | 3.79x | 0.9x | 15.82x | 16.07x | 1% | 6.88B | ||
| 16.12x | 1.7x | 1.79x | 0.72x | 7.52x | 9.46x | 2.31% | 5.91B | ||
| 13.78x | 2.07x | 0.85x | 0.88x | 6.37x | 8.34x | 3.11% | 3.9B | ||
| 13.96x | 4.27x | 6.49x | 1.19x | 7.29x | 13.71x | 5.48% | 3.16B | ||
| 14.12x | 2.64x | 0.68x | 0.58x | 4.64x | 7.65x | 4.9% | 3.09B | ||
| 14.62x | 6.61x | 2.23x | 0.88x | 6.64x | 9.23x | 4.39% | 2.96B | ||
| 39.46x | - | 1.26x | - | - | - | - | 2.56B | ||
| -91.83x | 2.89x | 1.49x | 0.46x | 17.01x | 103.36x | 0.01% | 1.51B | ||
| 21.12x | 3.7x | 0.92x | 0.61x | 7.84x | 12.84x | 1.95% | 1.51B | ||
| 11.72x | 0.84x | 0.11x | 0.27x | 2.67x | 5.51x | 4.33% | 928M | ||
| 14.44x | 2.39x | -0.55x | 0.85x | 6.89x | 14.83x | 5.79% | 915M | ||
| 42.14x | 4.02x | -6.48x | 0.98x | 12.99x | 23.28x | - | 899M | ||
| 25.87x | 7.05x | 0.96x | 0.94x | 12.77x | 19.79x | 1.38% | 776M | ||
| Average | 14.98x | 3.25x | 1.03x | 0.84x | 9.87x | 21.21x | 2.89% | 3.34B | |
| Weighted average by Cap. | 15.52x | 2.56x | 2.06x | 0.78x | 9.97x | 14.91x | 1.96% |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















